Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SUPRIYA.NS Stock Summary
Top 10 Correlated ETFs
SUPRIYA.NS
In the News
SUPRIYA.NS Financial details
Company Rating
Buy
Market Cap
27.43B
Income
1.2B
Revenue
5.54B
Book val./share
-
Cash/share
-
Dividend
0.6
Dividend %
0.2%
Employees
392
Optionable
No
Shortable
Yes
Earnings
29 May 2024
P/E
24.23
Forward P/E
17.9
PEG
-11.72
P/S
4.67
P/B
3.22
P/C
-
P/FCF
-
Quick Ratio
3.14
Current Ratio
6.26
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
14.96
EPS next Y
18.6
EPS next Q
-
EPS this Y
-40.83%
EPS next Y
24.33%
EPS next 5Y
53.07%
EPS last 5Y
-6.27%
Revenue last 5Y
10.65%
Revenue Q/Q
-0.01%
EPS Q/Q
24.58%
-
-
-
-
SMA20
-5.67%
SMA50
8.82%
SMA100
33.2%
Inst Own
-
Inst Trans
-
ROA
12%
ROE
28%
ROC
0.18%
Gross Margin
60%
Oper. Margin
27%
Profit Margin
19%
Payout
-
Shs Outstand
80.48M
Shs Float
21.41M
-
-
-
-
Target Price
-
52W Range
170.15-394.0
52W High
-15.49%
52W Low
+95.85%
RSI
50
Rel Volume
0.28
Avg Volume
649.24K
Volume
181.94K
Perf Week
1.74%
Perf Month
-7.41%
Perf Quarter
23.34%
Perf Half Y
19.44%
-
-
-
-
Beta
0.264
-
-
Volatility
5.21%, 14.58%
Prev Close
-1.93%
Price
332.95
Change
-0.91%
SUPRIYA.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 108.75 | 121.99 | 150.84 | 64.53 | 57.27 | |
Net income per share | 15.43 | 28.73 | 48.38 | 18.86 | 11.16 | |
Operating cash flow per share | 19.05 | 45.43 | 31.29 | 6.06 | 8.22 | |
Free cash flow per share | 16.33 | 35.83 | 12.4 | -1.38 | -5.24 | |
Cash per share | 4.85 | 29.24 | 35.01 | 27.95 | 20.38 | |
Book value per share | 36.71 | 58.4 | 105.27 | 76.5 | 86.91 | |
Tangible book value per share | 35.93 | 57.15 | 104.09 | 76.31 | 86.77 | |
Share holders equity per share | 36.71 | 58.4 | 105.27 | 76.5 | 86.91 | |
Interest debt per share | 40.16 | 35.76 | 29.86 | 3.76 | 3.17 | |
Market cap | 9.99B | 9.99B | 9.99B | 39.7B | 15.35B | |
Enterprise value | 10.89B | 10.81B | 10.4B | 38.32B | 14.72B | |
P/E ratio | 25.33 | 13.6 | 8.08 | 26.15 | 17.09 | |
Price to sales ratio | 3.59 | 3.2 | 2.59 | 7.64 | 3.33 | |
POCF ratio | 20.52 | 8.6 | 12.49 | 81.36 | 23.2 | |
PFCF ratio | 23.93 | 10.91 | 31.51 | -357.58 | -36.37 | |
P/B Ratio | 10.65 | 6.69 | 3.71 | 6.45 | 2.19 | |
PTB ratio | 10.65 | 6.69 | 3.71 | 6.45 | 2.19 | |
EV to sales | 3.92 | 3.47 | 2.7 | 7.38 | 3.19 | |
Enterprise value over EBITDA | 15.5 | 9.93 | 5.84 | 17.37 | 10.64 | |
EV to operating cash flow | 22.38 | 9.32 | 13.01 | 78.52 | 22.25 | |
EV to free cash flow | 26.1 | 11.81 | 32.81 | -345.12 | -34.88 | |
Earnings yield | 0.04 | 0.07 | 0.12 | 0.04 | 0.06 | |
Free cash flow yield | 0.04 | 0.09 | 0.03 | 0 | -0.03 | |
Debt to equity | 0.98 | 0.57 | 0.27 | 0.04 | 0.03 | |
Debt to assets | 0.37 | 0.25 | 0.16 | 0.04 | 0.03 | |
Net debt to EBITDA | 1.29 | 0.76 | 0.23 | -0.63 | -0.45 | |
Current ratio | 0.99 | 1.27 | 1.82 | 4.99 | 4.85 | |
Interest coverage | 5.98 | 14.72 | 40.78 | 72.69 | 37.99 | |
Income quality | 0.85 | 1.21 | 0.48 | 0.24 | 0.54 | |
Dividend Yield | 0 | 0.02 | 0 | 0 | 0 | |
Payout ratio | 0 | 0.24 | 0.03 | 0.03 | 0.05 | |
Sales general and administrative to revenue | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0 | 0 | |
Capex to operating cash flow | -0.14 | -0.21 | -0.6 | -1.23 | -1.64 | |
Capex to revenue | -0.02 | -0.08 | -0.13 | -0.12 | -0.24 | |
Capex to depreciation | -1.28 | -3.85 | -7.22 | -5.92 | -9.18 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 112.9 | 194.3 | 338.51 | 180.19 | 147.76 | |
ROIC | 0.22 | 0.33 | 0.36 | 0.23 | 0.12 | |
Return on tangible assets | 0.16 | 0.22 | 0.28 | 0.21 | 0.11 | |
Graham Net | -25.11 | -12.69 | 2.58 | 35.69 | 20.5 | |
Working capital | -19.82M | 426.05M | 1.2B | 3.98B | 3.69B | |
Tangible asset value | 918.04M | 1.46B | 2.66B | 6.14B | 6.98B | |
Net current asset value | -263.36M | 107.56M | 895.17M | 3.78B | 3.44B | |
Invested capital | 0.98 | 0.57 | 0.27 | 0.04 | 0.03 | |
Average receivables | 448.98M | 818.13M | 754.37M | 1.29B | 1.33B | |
Average payables | 429.4M | 467.6M | 502.07M | 499.97M | 566M | |
Average inventory | 312.15M | 400.95M | 609.7M | 823.96M | 1.04B | |
Days sales outstanding | 117.97 | 86.47 | 72.97 | 126.71 | 67.48 | |
Days payables outstanding | 92.82 | 110.77 | 123.2 | 77.75 | 129.66 | |
Days of inventory on hand | 64.64 | 110.92 | 175.01 | 146.57 | 233.7 | |
Receivables turnover | 3.09 | 4.22 | 5 | 2.88 | 5.41 | |
Payables turnover | 3.93 | 3.3 | 2.96 | 4.69 | 2.82 | |
Inventory turnover | 5.65 | 3.29 | 2.09 | 2.49 | 1.56 | |
ROE | 0.42 | 0.49 | 0.46 | 0.25 | 0.13 | |
Capex per share | -2.72 | -9.6 | -18.88 | -7.44 | -13.47 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 13.04 | 17.69 | 16.4 | 17.42 | 17.4 | |
Net income per share | 1.18 | 4.75 | 3.54 | 2.97 | 3.7 | |
Operating cash flow per share | 0.73 | 0.75 | 0.98 | 0.99 | 0.98 | |
Free cash flow per share | 0.73 | 0.75 | 0.98 | 0.99 | 0.98 | |
Cash per share | 23.52 | 20.39 | 19.58 | 14.96 | 0 | |
Book value per share | 80.88 | 86.95 | 86.91 | 93.66 | 0 | |
Tangible book value per share | 0 | 86.82 | 0 | 93.5 | 0 | |
Share holders equity per share | 80.88 | 86.95 | 86.91 | 93.66 | 0 | |
Interest debt per share | 0.13 | 2.88 | 0.1 | 0.77 | 0.06 | |
Market cap | 18.95B | 15.34B | 19.95B | 22.59B | 25.33B | |
Enterprise value | 20.84B | 14.72B | 21.52B | 21.61B | 25.33B | |
P/E ratio | 49.8 | 10.03 | 17.49 | 23.64 | 21.26 | |
Price to sales ratio | 18.02 | 10.78 | 15.11 | 16.12 | 18.08 | |
POCF ratio | 321.11 | 255.13 | 252.18 | 283.71 | 319.85 | |
PFCF ratio | 321.11 | 255.13 | 252.18 | 283.71 | 319.85 | |
P/B Ratio | 2.91 | 2.19 | 2.85 | 3 | 0 | |
PTB ratio | 2.91 | 2.19 | 2.85 | 3 | 0 | |
EV to sales | 19.82 | 10.34 | 16.3 | 15.42 | 18.08 | |
Enterprise value over EBITDA | 125.5 | 25.81 | 45.4 | 63.14 | 56.86 | |
EV to operating cash flow | 353.24 | 244.7 | 272.1 | 271.37 | 319.85 | |
EV to free cash flow | 353.24 | 244.7 | 272.1 | 271.37 | 319.85 | |
Earnings yield | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0.03 | 0 | 0.01 | 0 | |
Debt to assets | 0 | 0.03 | 0 | 0.01 | 0 | |
Net debt to EBITDA | 11.42 | -1.1 | 3.32 | -2.87 | 0 | |
Current ratio | 0 | 4.85 | 0 | 6.26 | 0 | |
Interest coverage | 13.47 | 75.95 | 49.68 | 65.73 | 82.17 | |
Income quality | 0.62 | 0.16 | 0.28 | 0.33 | 0.27 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.05 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 46.34 | 96.43 | 83.23 | 79.11 | 0 | |
ROIC | 0.02 | 0.05 | 0.04 | 0.03 | 0 | |
Return on tangible assets | 0 | 0.05 | 0 | 0.03 | 0 | |
Graham Net | 23.52 | 20.51 | 19.58 | 17.89 | 0 | |
Working capital | 1.9B | 3.69B | 1.58B | 3.45B | 0 | |
Tangible asset value | 0 | 6.98B | 0 | 7.52B | 0 | |
Net current asset value | 1.9B | 3.44B | 1.58B | 3.21B | 0 | |
Invested capital | 0 | 0.03 | 0 | 0.01 | 0 | |
Average receivables | 403.5M | 426.07M | 426.07M | 426.96M | 426.96M | |
Average payables | 269.13M | 321.14M | 321.14M | 275.99M | 275.99M | |
Average inventory | 531.51M | 578.85M | 578.85M | 494.13M | 494.13M | |
Days sales outstanding | 0 | 53.91 | 0 | 54.86 | 0 | |
Days payables outstanding | 0 | 121.54 | 0 | 80.59 | 0 | |
Days of inventory on hand | 0 | 219.07 | 0 | 144.3 | 0 | |
Receivables turnover | 0 | 1.67 | 0 | 1.64 | 0 | |
Payables turnover | 0 | 0.74 | 0 | 1.12 | 0 | |
Inventory turnover | 0 | 0.41 | 0 | 0.62 | 0 | |
ROE | 0.01 | 0.05 | 0.04 | 0.03 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
SUPRIYA.NS Frequently Asked Questions
What is Supriya Lifescience Limited stock symbol ?
Supriya Lifescience Limited is a IN stock and trading under the symbol SUPRIYA.NS
What is Supriya Lifescience Limited stock quote today ?
Supriya Lifescience Limited stock price is $332.95 today.
Is Supriya Lifescience Limited stock public?
Yes, Supriya Lifescience Limited is a publicly traded company.